Abstract

Tissue resident adult stem cells are known to participate in tissue regeneration and repair that follows cell turnover, or injury. It has been well established that aging impedes the regeneration capabilities at the cellular level, but it is not clear if the different onset of stem cell aging between individuals can be predicted or prevented at an earlier stage. Here we studied the dental pulp stem cells (DPSCs), a population of adult stem cells that is known to participate in the repair of an injured tooth, and its properties can be affected by aging. The dental pulp from third molars of a diverse patient group were surgically extracted, generating cells that had a high percentage of mesenchymal stem cell markers CD29, CD44, CD146 and Stro1 and had the ability to differentiate into osteo/odontogenic and adipogenic lineages. Through RNA seq and qPCR analysis we identified homeobox protein, Barx1, as a marker for DPSCs. Furthermore, using high throughput transcriptomic and proteomic analysis we identified markers for DPSC populations with accelerated replicative senescence. In particular, we show that the transforming growth factor-beta (TGF-β) pathway and the cytoskeletal proteins are upregulated in rapid aging DPSCs, indicating a loss of stem cell characteristics and spontaneous initiation of terminal differentiation. Importantly, using metabolic flux analysis, we identified a metabolic signature for the rapid aging DPSCs, prior to manifestation of senescence phenotypes. This metabolic signature therefore can be used to predict the onset of replicative senescence. Hence, the present study identifies Barx1 as a DPSCs marker and dissects the first predictive metabolic signature for DPSCs aging.

Details

Title
Metabolism as an early predictor of DPSCs aging
Author
Macrin Dannie 1 ; Alghadeer Ammar 2 ; Zhao, Yan Ting 3 ; Miklas, Jason W 4 ; Hussein, Abdiasis M 5 ; Detraux Damien 5 ; Robitaille, Aaron M 6   VIAFID ORCID Logo  ; Madan Anup 7 ; Moon, Randall T 6 ; Wang, Yuliang 8 ; Devi Arikketh 9 ; Mathieu, Julie 10 ; Ruohola-Baker Hannele 11 

 University of Washington, School of Medicine, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); SRM Institute of Science and Technology, Department of Genetic Engineering, Chennai, India (GRID:grid.412742.6) (ISNI:0000 0004 0635 5080) 
 University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Dentistry, Department of Oral Health Sciences, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); Imam Abdulrahman bin Faisal University, College of Dentistry, Department of Biomedical Dental Sciences, Dammam, Saudi Arabia (GRID:grid.411975.f) (ISNI:0000 0004 0607 035X) 
 University of Washington, School of Medicine, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Dentistry, Department of Oral Health Sciences, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Department of Bioengineering, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington, School of Medicine, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Department of Pharmacology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 Covance Genomics Laboratory, Redmond, USA (GRID:grid.34477.33) 
 University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Paul G. Allen School of Computer Science and Engineering, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); SRM Institute of Science and Technology, Department of Genetic Engineering, Chennai, India (GRID:grid.412742.6) (ISNI:0000 0004 0635 5080) 
10  University of Washington, School of Medicine, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Medicine, Department of Comparative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
11  University of Washington, School of Medicine, Department of Biochemistry, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Medicine, Institute for Stem Cell and Regenerative Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, School of Dentistry, Department of Oral Health Sciences, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Department of Bioengineering, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2183742231
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.